Skip to main content
Log in

Clomifen oder FSH zur ovariellen Stimulation beim polyzystischen Ovarsyndrom?

Clomiphene or FSH for ovarian stimulation in polycystic ovary syndrome?

  • Journal Club
  • Published:
Gynäkologische Endokrinologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47

    Article  Google Scholar 

  2. Lopez E, Gunby J, Daya S et al (2004) Ovulation induction in women with polycystic ovary syndrome: randomized trial of clomiphene citrate versus low-dose recombinant FSH as first line therapy. Reprod Biomed Online 9:382–390

    Article  PubMed  CAS  Google Scholar 

  3. Brown J, Farquhar C, Beck J et al (2009) Clomiphene and anti-oestrogens for ovulation induction in PCOS. Cochrane Database Syst Rev:CD002249

    Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Fluhr.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fluhr, H. Clomifen oder FSH zur ovariellen Stimulation beim polyzystischen Ovarsyndrom?. Gynäkologische Endokrinologie 10, 193–194 (2012). https://doi.org/10.1007/s10304-012-0502-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10304-012-0502-x

Navigation